Study S000496

Liraglutide With or Without NEAT in Type 2 Diabetes Mellitus; Effects on HbA1c, Weight, Blood Pressure, Quality of Life and Health Care Costs.

Name: LivingGLP1 adjudicated trial data and network meta-analysis results
Creator: Ahmad Sofi-Mahmudi
License: https://creativecommons.org/licenses/by/4.0/

ClinicalTrials.gov record

Registration

Registration: NCT01638260
Study type: INTERVENTIONAL
Allocation: RANDOMIZED
Phase: PHASE4
Masking: NONE
Status: TERMINATED
Enrollment: 22
Start: 2012-10
Primary completion: 2013-11
Lead sponsor: Maastricht University Medical Center
Conditions: Type 2 Diabetes Mellitus
Interventions: DRUG:Liraglutide; BEHAVIORAL:NEAT
Results posted: FALSE

Registered primary outcomes

Change in HbA1c from baseline and end of treatment (26 weeks) and end of follow-up (52 weeks) [6 times, screening, week 0, week 13-26-39-52]
Change in weight from baseline and end of treatment (26 weeks) and end of follow-up (52 weeks) [6 times, screening, week 0, week 13-26-39-52]

Linked records (0)

Automatic links, confirmed or rejected during screening. A record citing this registration may be a secondary analysis, a commentary or a review that mentions the trial.

No records link to this registration yet.